MENU

NDRA Stock Tickeron detected bearish Stock Pattern: Triangle Symmetrical Bottom NDRA on October 07, 2024, netting in a 16.64% gain over 1 month

A.I.dvisor
at Tickeron.com
11/09/24
Loading...
+16.64% Gain from a Successful pattern Triangle Symmetrical Bottom
NDRA - ENDRA Life Sciences Inc
Tickeron
Ticker: NDRA
Company: ENDRA Life Sciences
Gain from shortening: +16.64%
Confirmed: 10/07/24
Succeeded: 11/07/24
Total length: 31 days
On October 07, 2024, A.I.dvisor detected a Triangle Symmetrical Bottom Pattern (Bearish) for ENDRA Life Sciences Inc (NDRA, $7.10). On October 07, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 07, 2024, the stock hit the target price of $6.18 – resulting in a +1 gain for traders who shorted the stock on the pattern detection date.

NDRA's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for NDRA moved out of overbought territory on October 23, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NDRA as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NDRA moved below its 50-day moving average on November 04, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NDRA crossed bearishly below the 50-day moving average on November 11, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NDRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NDRA broke above its upper Bollinger Band on October 22, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NDRA entered a downward trend on October 18, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.855) is normal, around the industry mean (22.875). P/E Ratio (0.000) is within average values for comparable stocks, (83.945). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (42.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NDRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NDRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
NDRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medical imaging technology solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3600 Green Court
Phone
+1 734 335-0468
Employees
21
Web
https://www.endrainc.com